China: Partnering for innovations in commercial health insurance
China commercial health insurance (CHI) features vibrant growth on one hand, and complexities and variances on the other. A strategic approach is key for major pharma and medtech pharmaceutical firms to prioritize CHI opportunities, and to take part in the ongoing optimizations and innovations.
| Blog | Healthcare & Life Sciences Medtech Pharma & Biotechnology